Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hailin Tang

Showing results (191-200 of 341) with videos related to

Pageof 35
Sort By:
Journal of Hematology & Oncology|March 7, 2020
Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancerShaoquan Zheng, Lu Yang, Yutian Zou, et al.
Molecular Cancer|February 13, 2019
circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancerHailin Tang, Xiaojia Huang, Jin Wang, et al.
Molecular Cancer|March 22, 2025
Correction: The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadinZehao Wang, Lu Yang, Peng Wu, et al.
Oncotarget|May 5, 2016
mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPKPeng Liu, Feng Ye, Xinhua Xie, et al.
Current Cancer Drug Targets|November 8, 2017
Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK SignalingXinhua Xie, Xiaojia Huang, Hailin Tang, et al.
Scientific Reports|February 24, 2016
The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancerXiangsheng Xiao, Xiaojia Huang, Feng Ye, et al.
Antiviral Research|September 5, 2025
DMBT1 promotes SARS-CoV-2 infection and its SRCR-derived peptide inhibits SARS-CoV-2 infectionChenxi Zhu, Ziqiao Wang, Zhendong Pan, et al.
Oncotarget|June 4, 2015
MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancerXiaoping Liu, Hailin Tang, Jianping Chen, et al.
Theranostics|August 8, 2018
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer ProgressionBo Chen, Weidong Wei, Xiaojia Huang, et al.
Cancer Letters|October 12, 2014
miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancerBo Chen, Hailin Tang, Xiaoping Liu, et al.
Pageof 35

Showing results (191-200 of 341) with videos related to

Sort By:
Pageof 35
Journal of Hematology & Oncology|March 7, 2020
Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancerShaoquan Zheng, Lu Yang, Yutian Zou, et al.
Molecular Cancer|February 13, 2019
circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancerHailin Tang, Xiaojia Huang, Jin Wang, et al.
Molecular Cancer|March 22, 2025
Correction: The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadinZehao Wang, Lu Yang, Peng Wu, et al.
Oncotarget|May 5, 2016
mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPKPeng Liu, Feng Ye, Xinhua Xie, et al.
Current Cancer Drug Targets|November 8, 2017
Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK SignalingXinhua Xie, Xiaojia Huang, Hailin Tang, et al.
Scientific Reports|February 24, 2016
The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancerXiangsheng Xiao, Xiaojia Huang, Feng Ye, et al.
Antiviral Research|September 5, 2025
DMBT1 promotes SARS-CoV-2 infection and its SRCR-derived peptide inhibits SARS-CoV-2 infectionChenxi Zhu, Ziqiao Wang, Zhendong Pan, et al.
Oncotarget|June 4, 2015
MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancerXiaoping Liu, Hailin Tang, Jianping Chen, et al.
Theranostics|August 8, 2018
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer ProgressionBo Chen, Weidong Wei, Xiaojia Huang, et al.
Cancer Letters|October 12, 2014
miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancerBo Chen, Hailin Tang, Xiaoping Liu, et al.
Pageof 35